Internal Server Error

About SINE

SINE, an accelerator and incubator program founded in 2004, is based in Mumbai, India. With a presence in 3 countries, it has supported around 231 startups in sectors like Enterprise Applications, High Tech. As of Apr 2026, SINE has witnessed 6 portfolio exits. Most notable companies in its portfolio include Atomberg, Seclore and SEDEMAC. The program is backed by a team of 46 people who primarily support Seed startups based in India. Its latest investment was a $487K Seed round in BAAS Technologies on Nov 22, 2025, which also saw participation from Inflection Point Ventures and Rajesh Arora.
Key Metrics
Founded Year
2004
Location
Mumbai, India
Portfolio Companies
Sectors of Investment
Stages of Investment
Seed & Grant (prize money)
Locations of Investment

SINE's List of Top Investments

SINE has a portfolio of 231 companies. Their most notable investments are in Vytal and Vytal.Their portfolio spans across India, United States and United Kingdom. They have invested in Enterprise Applications, High Tech, HealthTech and 32 other sectors, across stages such as Seed, Grant (prize money) stages. Here is the list of top investments by SINE:
Provider of energy-efficient ceiling fans and smart home appliances. Offers ceiling fans, mixer grinders, water purifiers and more. Their products combine innovative technology with sleek design to enhance comfort and reduce energy consumption. They focus on sustainability and smart connectivity to improve user experience in homes.

Key facts about Atomberg

  • Founded Year: 2012
  • Location: Mumbai (India)
  • Annual Revenue: ₹1,000Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series C
  • Total Funding till date: $119M
  • Employee Count: 832 as on Aug 31, 2025
  • Investors: Temasek, Steadview and 22 Others
  • Latest Funding Round: Series C, Oct 17, 2025, $*****
  • Highlight: Editors' Pick
Provider of data-centric security software for preventing data theft and compliance. The platform facilitates discovery, classification, protection, monitoring, and tracking of sensitive digital assets. It offers digital asset classification, enterprise digital rights management, and risk insights. The platform provides APIs, SDKs, and email encryption. It integrates with data loss prevention, cloud access security brokers, and SIEM tools.

Key facts about Seclore

Manufacturer of motor vehicle parts. Its product portfolio includes sensorless integrated starter generators, ECUs for fuel injection, smart ignition, voltage regulators, battery management systems, connectivity devices, generator controllers, and battery chargers. It supplies critical-to-the-application control products in large volumes, from in-house lines, to leaders of large markets.

Key facts about SEDEMAC

  • Founded Year: 2007
  • Location: Mumbai (India)
  • Annual Revenue: ₹663Cr as on Mar 31, 2025
  • Stage: Public
  • Total Funding till date: $25.8M
  • Employee Count: 518 as on Jul 31, 2025
  • Investors: 360 One, Nexus Venture Partners and 23 Others
  • Latest Funding Round: Series B, Apr 23, 2025, $*****
  • Highlight: Public
Provider of quantum cryptography solutions, key distribution, random number generation. It offers quantum key distribution for secure cryptographic keys and quantum random number generators. It provides post-quantum cryptography algorithms resistant to quantum attacks. It delivers quantum-safe virtual private networks, secure tunnels, and messaging services.

Key facts about QNu Labs

  • Founded Year: 2016
  • Location: Bengaluru (India)
  • Annual Revenue: ₹40.5Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series A
  • Total Funding till date: $22.3M
  • Employee Count: 118 as on Aug 31, 2025
  • Investors: HDFC Bank, Astir Ventures and 90 Others
  • Latest Funding Round: Series A, Apr 24, 2025, $*****
  • Highlight: Editors' Pick
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia. It offers other pipeline products which include Actalycabtagene autoleucel​ for B-lymphoid malignancies​, HCAR2 for multiple myeloma, and HCAr3 for Glioblastoma multiforme, and neuroblastoma​.

Key facts about ImmunoACT

  • Founded Year: 2018
  • Location: Mumbai (India)
  • Annual Revenue: ₹67.6Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series B
  • Total Funding till date: $15.9M
  • Employee Count: 204 as on Aug 31, 2025
  • Investors: SINE, BIRAC and 4 Others
  • Latest Funding Round: Series B, May 31, 2023, $*****
  • Highlight: Editors' Pick

SINE's Investments by Stage

SINE has made 76 investments in Seed stage with an average round size of $166K and 2 investments in Grant (prize money) stage with an average round size of $72.1K.
Here are SINE's investments by stage:
Stage of entry
No. of Investments
Seed
76
Grant (prize money)
2
Breakdown of SINE's investments by stage of entrySeed (76)Grant (prize money) (2)
Note: We have considered here, only first round of investments

SINE's Investments by Sector

SINE has a diverse portfolio, with companies operating in the High Tech, Enterprise Applications, Sustainability Tech, Life Sciences and HealthTech. Notably, it has invested in 166 Enterprise (B2B) companies, 166 Tech companies, 87 Software companies and at least 71 companies focusing on Tech hardware.
Here are SINE's investments by sector:
Sector
No. of Investments
High Tech
33
Enterprise Applications
19
Sustainability Tech
18
Life Sciences
17
HealthTech
16
Others
116
Breakdown of SINE's investments by sectorsHigh Tech (33)Enterprise Applic... (19)
Note: We have considered here, only first round of investments

SINE's Investments by Geography

SINE has made most investments in India (77), followed by United States where it has made 1 investment.
Here are SINE's investments by geography:
Country
No. of Investments
India
77
United States
1
Breakdown of SINE's investments by countriesIndia (77)
Note: We have considered here, only first round of investments

SINE's recent investments

SINE has not made any investment in 2026 so far.
Here are the most recent investments by SINE:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Nov 22, 2025
India
Seed
4969
Oct 06, 2025
India
Seed
6880
Aug 11, 2025
India
Seed
3617
Jul 11, 2025
India
Seed
8661
-
Apr 11, 2025
India
Seed
7661
-

IPOs and Publicly Listed companies in SINE's Portfolio

2 of SINE's portfolio companies have become public. SEDEMAC got listed on the Bombay Stock Exchange (BSE), in Mar 2026 at marketcap of $650M and ideaForge got listed on the National Stock Exchange (NSE), Bombay Stock Exchange (BSE) at marketcap of $339M.
Here are SINE's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Mar 11, 2026
-
-
8840
Jul 07, 2023
-
-
1142

Acquired companies in SINE's Portfolio

4 companies from SINE's portfolio have been acquired. The most recent acquisition were Getcogno.ai in Nov 2021 by Exotel.
Here are SINE's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Nov 11, 2021
Nov 07, 2017
Seed
9486
Nov 11, 2021
Nov 07, 2017
Seed
2366
Jun 01, 2019
-
-
6025
May 11, 2016
-
-
3703

Team profile of SINE

SINE has a team of 46 members including 8 Partners, 2 Venture Partners and 7 Principals located in India. SINE's team does not sit on the board of any company as of now.
Here is a list of top team members in SINE:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Mumbai
-
Partner
-
-
-
Partner
Mumbai
-
-
Partner
-
-
-
Partner
-
-
-
Partner
-
-
-
Partner
Mumbai
-
-
Partner
Mumbai
-
-
Venture Partner
-
-
Venture Partner
Mumbai
-
-
Principal
Mumbai
-

Co-investors of SINE

Over the past 12 years, 841 investors have co-invested in SINE's portfolio companies. This includes funds and angels.

Recent News related to SINE

View all news related to SINE

FAQs about SINE

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford